A gene therapy stamp? not in this Century
Jenks, S.
Journal of the National Cancer Institute 91(15): 1277
1999
ISSN/ISBN: 0027-8874 PMID: 10433613 Document Number: 504898
Document emailed within 1 workday
Related Documents
Tong, X.W.; Engehausen, D.G.; Kaufman, R.H.; Agoulnik, I.; Contant, C.; Freund, C.T.; Oehler, M.K.; Kim, T.E.; Hasenburg, A.; Woo, S.L.; Kieback, D.G. 1998: Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy Anticancer Research 18(2a): 713-718Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267
Wurm, H. 1985: Hypotheses and causes of body height progressions since mid 19th century--a scientific historical review. I: Discussion of causes since the end of the 19th century to mid 20th century, including references on body height development in the 19th century Gegenbaurs Morphologisches Jahrbuch 131(5): 589-610
Bubeník, J.; Zeuthen, J.; Bubeníková, D.; Símová, J.; Jandlová, T. 1993: Gene therapy of cancer: use of IL-2 gene transfer and kinetics of local T and NK cell subsets Anticancer Research 13(5a): 1457-1460
Grgić, M. 2000: Gene therapy of tumors of the head and neck: clinical use of the p53 tumor suppressor gene Lijecnicki Vjesnik 122(1-2): 14-16
Guo, M.-g.; Jiang, M.-h.; Yang, Q.; Li, Y.-m.; Cui, Z.-f.; Li, L.-f.; Wu, M.-c.; Qian, Q.-j. 2004: Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene Zhonghua Yi Xue Za Zhi 84(14): 1147-1151
Yoon, S.J.; Heo, D.S.; Kang, J.O.; Kim, N.K. 1999: Combination gene therapy of IL-12 and allogeneic MHC class i gene via stimulating NK cytolytic activity Anticancer Research 19(5b): 4337-4342
Bellon, G. 1998: From gene transfer to gene therapy in cystic fibrosis, how long is the road? La Revue du Praticien 48(1): 5-8
Kaneda, Y.; Morishita, R. 1997: Development of in vivo gene transfer methods towards future gene therapy Rinsho Byori. Japanese Journal of Clinical Pathology 45(2): 99-105
Cooper, M.J. 1996: Noninfectious gene transfer and expression systems for cancer gene therapy Seminars in Oncology 23(1): 172-187
Zentilin, L.; Tafuro, S.; Serra, C.; Falaschi, A.; Giacca, M. 1998: Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells Annali Dell'istituto Superiore di Sanita 34(4): 447-455
Zhao, M.; Xiao, S.-w.; Yang, J.-x.; Zhang, S.-w.; Lü, Y.-y. 2005: Detection of p53 gene change and serum antibody level in phase Ii clinical trial of ad p53 gene therapy Zhonghua Yi Xue Za Zhi 85(49): 3495-3498
Huang, X.; Cao, X.; Zhang, W. 1998: Enhanced antitumor effect of suicide gene therapy by SCF, GM-CSF gene transfer in vivo and its immunological mechanism Zhonghua Zhong Liu Za Zhi 20(4): 270-273
Sun, X.-Y.; Wu, Z.-D.; Hu, J.-B. 2002: Suicide gene therapy of hepatocellular carcinoma and delivery procedure and route of therapeutic gene in vivo Hepatobiliary and Pancreatic Diseases International: Hbpd Int 1(3): 373-377
Caplan, A.I.; Mosca, J.D. 2000: Orthopaedic gene therapy. Stem cells for gene delivery Clinical Orthopaedics and Related Research 2000(379(Suppl): S98-100
Huff, B. 2003: Gene genie. can gene therapy deliver a better fusion blocker? Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 17(12): 7
Tamiya, T.; Ohmoto, T.; Wei, M.X.; Breakfield, X.O.; Chiocca, E.A. 1994: Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4) No Shinkei Geka. Neurological Surgery 22(12): 1099-1110
Nitta, T. 1994: Gene therapy for brain tumors: antitumor effects of introduction of antisense and tumor suppressor gene (series 2) No Shinkei Geka. Neurological Surgery 22(10): 903-909
Setoguchi, Y.; Tamaki, Y.; Oka, M.; Kira, S. 1996: Transfer of endothelial nitric oxide synthase gene in the purpose of gene therapy for pulmonary arterial hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 54(2): 369-376
Vile, R.G.; Nelson, J.A.; Castleden, S.; Chong, H.; Hart, I.R. 1994: Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component Cancer Research 54(23): 6228-6234